Atomos finds profit after years of losses as product reset takes hold

Profit returns, but the balance sheet remains under pressure

Atomos Limited (ASX:AMS) has cleared the first hurdle of its turnaround: the group reported an audited A$0.9 million profit after tax for FY26, compared with a A$14.6 million loss a year earlier. Revenue rose 22.5% to A$40.0 million, while EBITDA improved from a loss of A$11.8 million to a profit of A$3.7 million. Management said the business delivered four consecutive EBITDA-positive quarters after 14 quarters of losses.

The improvement was substantial, but not self-sustaining by default. Atomos ended June with negative net assets of A$2.6 million, cash of A$2.3 million and total borrowings of A$20.9 million. Operating activities consumed A$5.0 million of cash during the year, although that was a marked improvement on the A$13.3 million outflow in FY25.

Margins benefited from restructuring and temporary factors

Contribution margin more than doubled to A$14.9 million, or 37.2% of revenue, from 16.8% in FY25. The gain reflected lower product and freight costs, distribution changes, reduced discounting and the effect of changing United States tariff settings. It also included A$1.7 million of provision releases; excluding those releases, contribution margin was 33.0%, within the 33% to 35% range Atomos says it expects to sustain.

Fixed costs fell 22.5% to A$12.5 million after the previous year’s restructuring, leaving average monthly fixed costs at about A$1.1 million. That cost base helped EBITDA hold at A$1.8 million in the second half despite revenue falling to A$16.3 million from A$23.7 million in the first half. The quality of that resilience will be tested against a full period of normal trading rather than the tariff-related timing effects recorded in FY26.

Flanders adds reach and another concentration risk

Atomos launched or upgraded seven products during the year, including the Ninja TX range, Shinobi 7 RX, Shogun AV-19 and Sumo PRO 19. It also acquired Flanders Scientific on 24 April for total consideration of A$2.5 million, comprising cash, Atomos shares and contingent consideration. Flanders contributed A$1.8 million of revenue and a A$13,000 loss after tax in the ten weeks after completion.

The acquisition extends Atomos into professional reference monitoring and should provide a full-year contribution in FY27. It also brings a material dependency: approximately 90% of Flanders’ revenue comes from a single exclusive global distribution arrangement. The related supply agreement was valued at A$1.65 million, with the acquisition accounting still provisional and based on management estimates rather than an independent valuation.

Covenant test is the immediate financial fault line

Atomos refinanced with a new A$10.0 million Commonwealth Bank of Australia facility and reduced the cost of the related-party Monreii facility from 20% to 13% a year, saving about A$0.7 million in annual interest according to the report. Shareholders also exercised listed options during FY26, generating A$7.8 million that was applied to debt. The Monreii facility was subsequently extended to 28 February 2028.

Yet the CBA facility requires minimum EBITDA of A$5.0 million for each six-month period from 31 December 2026. Atomos’ forecasts indicate that it may not meet that threshold, and a breach could allow CBA to demand repayment while triggering a cross-default under the Monreii facility. The directors are seeking revised covenant terms, but the annual review is not due to be completed until 31 December 2026. The auditor issued an unmodified opinion while highlighting a material uncertainty that may cast significant doubt on the group’s ability to continue as a going concern.